Member Societies

• All
• Nov. 18 (Thu)
• Nov. 19 (Fri)
• Nov. 20 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Joint Session between KDDW-TDDW-JDDW
• Others
• Free Paper
• Satellite Symposium

Symposium 01 (KASL) : Distinguished Research of 2021 in Liver Disease Korean

Date / Time	Nov. 18 (Thu), 08:30-10:00
Channel	Channel 1
Chair(s)	Myung Seok Lee (Hallym Univ., Korea) Jong Eun Yeon (Korea Univ., Korea)
Speakers	08:30-08:52	Viral hepatitis Hyun Woong Lee (Yonsei Univ., Korea)
	08:52-09:14	Alcoholic and nonalcoholic liver disease Byoung Kuk Jang (Keimyung Univ., Korea)
	09:14-09:36	Liver cirrhosis and complications Byung Seok Kim (Daegu Catholic Univ., Korea)
	09:36-09:58	Hepatocellular carcinoma Jooho Lee (CHA Univ., Korea)

Memorial Lecture (KASL) : Chung Yong Kim Memorial Lecture Korean

Date / Time	Nov. 18 (Thu), 10:15-10:45
Channel	Channel 1
Chair	Dong Joon Kim (Hallym Univ., Korea)
Speaker	10:15-10:45	Beyond the best with humanity and creativity Kwang-Hyub Han (National Evidence-based Healthcare Collaborating Agency (NECA), Korea)

General Meeting Korean

Date / Time	Nov. 18 (Thu), 10:45-11:45
Channel	Channel 1

Symposium 03 (KASL) : AI Application in Future Hepatology Korean

Date / Time	Nov. 18 (Thu), 12:25-13:55
Channel	Channel 1
Chair(s)	Chul Ju Han (Korea Cancer Center Hosp., Korea) Yun Soo Kim (Gachon Univ., Korea)
Speakers	12:25-12:47	The application of texture quantification in hepatocellular carcinoma using CT and MRI Kwang Gi Kim (Gachon Univ., Biomedical Engineering, Korea)
	12:47-13:09	Next generation diagnostic pathology: Artificial intelligence-powered diagnosis and biomarker analysis Chan-Young Ock (Lunit Inc., Korea)
	13:09-13:31	Utilization of digital healthcare big data Young-Hak Kim (Univ. of Ulsan, Cardiology, Korea)
	13:31-13:53	Profiling based identification and application of non-coding RNAs as biomarker for hepatocellular carcinoma Keun Hur (Kyungpook National Univ., Biochemistry and Cell Biology, Korea)

Symposium 07 (KASL) : Clinical Decision in Chronic Liver Diseases Korean

Date / Time	Nov. 18 (Thu), 14:10-15:40
Channel	Channel 1
Chair(s)	Jin Mo Yang (The Catholic Univ. of Korea, Korea) Kwang Cheol Koh (Sungkyunkwan Univ., Korea)
Speakers	14:10-14:32	The assessment of NAFLD using diagnostic algorithm Dae Won Jun (Hanyang Univ. Hosp., Korea)
	14:32-14:54	The sequential application of systemic chemotherapy in advanced HCC Bo Hyun Kim (National Cancer Center, Korea)
	14:54-15:16	The treatment of nonselective beta blocker to patients with varices: (Who, When, and Which drug) Moon Young Kim (Yonsei Univ. Wonju, Korea)
	15:16-15:38	The selection of proper anti-viral agents to patients with CHB in each condition Jun Yong Park (Yonsei Univ., Korea)

Symposium 11 (KASL) : Liver Disease and Vaccination Korean

Date / Time	Nov. 18 (Thu), 15:55-17:25
Channel	Channel 1
Chair(s)	Han Chu Lee (Univ. of Ulsan, Korea) Oh Sang Kwon (Gachon Univ., Korea)
Speakers	15:55-16:17	The present and future of therapeutic vaccine for viral hepatitis B Kyun-Hwan Kim (Sungkyunkwan Univ., Precision Medicine, Korea)
	16:17-16:39	The present and future of therapeutic or preventative vaccine for viral hepatitis C Eui-Cheol Shin (Korea Advanced Institute of Science and Technology, Korea)
	16:39-17:01	COVID-19 vaccination in patients with chronic liver disease Jung Yeon Heo (Ajou Univ., Infectious Diseases, Korea)
	17:01-17:23	Vaccination strategy for patients with chronic liver disease and liver transplantation Eunjung Lee (Soonchunhyang Univ., Infectious Diseases, Korea)

KASL-AASLD Joint Symposium 01 (KASL) : COVID-19 and the Management of Chronic Liver Diseases English

Date / Time	Nov. 19 (Fri), 08:30-10:00
Channel	Channel 3
Chair(s)	Joong-Won Park (National Cancer Center, Korea) Steven Flamm (Northwestern Univ., USA)
Speakers	08:30-09:00	Pathogenesis and outcomes of COVID-19 in patients with chronic liver disease Andrew Moon (Univ. of North Carolina, USA)
	09:00-09:30	COVID-19 in liver transplantation Elizabeth C. Verna (Columbia Univ., USA)
	09:30-10:00	COVID-19 vaccination for patients with chronic liver diseases Won Suk Choi (Korea Univ., Infectious Diseases, Korea)

KASL-AASLD Joint Symposium 02 (KASL) : Recent Update of Fatty Liver Disease English

Date / Time	Nov. 19 (Fri), 10:15-11:45
Channel	Channel 3
Chair(s)	Seung Woon Paik (Sungkyunkwan Univ., Korea) Mauricio Lisker-Melman (Washington Univ., USA)
Speakers	10:15-10:45	A unique phenotype of NAFLD: NAFLD with sarcopenia Won Kim (Seoul National Univ., Korea)
	10:45-11:15	Recent updates of clinical trials on NASH Mary Eugenia Rinella (The Univ. of Chicago, USA)
	11:15-11:45	Influence of NAFLD on chronic hepatitis B and C Seung Up Kim (Yonsei Univ., Korea)

KASL-AASLD Joint Symposium 03 (KASL) : Changes in the Management of Chronic Hepatitis B English

Date / Time	Nov. 19 (Fri), 12:25-13:55
Channel	Channel 3
Chair(s)	Jung-Hwan Yoon (Seoul National Univ., Korea) Joseph Ahn (Oregon Health Science Univ., USA)
Speakers	12:25-12:55	Artificial intelligence-driven HCC prediction model for patients with chronic hepatitis B Hwi Young Kim (Ewha Womans Univ., Korea)
	12:55-13:25	Expanding treatment criteria for chronic hepatitis B Young-Suk Lim (Univ. of Ulsan, Korea)
	13:25-13:55	Recent updates of clinical trials on functional cure of chronic hepatitis B W Ray Kim (Stanford Univ., USA)

Basic/Translational Symposium 04 (KASL) : Basic Science Forum of Liver Disease: Metabolic Approaches for the Translational Medicine of Liver Diseases English

Date / Time	Nov. 19 (Fri), 14:10-15:40
Channel	Channel 3
Chair(s)	Young Oh Kweon (Kyungpook National Univ., Korea) Si Hyun Bae (The Catholic Univ. of Korea, Korea)
Speakers	14:10-14:32	Small intestinal dietary fructose metabolism prevents non-alcoholic fatty liver disease Cholsoon Jang (Univ. of California, Irvine, USA)
	14:32-14:54	Microbial metabolites entering into the liver: The role in diabetes and drug responses Ara Koh (POSTECH, Korea)
	14:54-15:16	Fructose modulates leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and Nitrative stress Young-Eun Cho (Andong National Univ., Food and Nutrition, Korea)
	15:16-15:38	Role of diabetes on the risk of hepatocellular carcinoma in cirrhosis patients with NAFLD Ju Dong Yang (Cedars-Sinai Medical Center, USA)

Multidisciplinary Session 02 (KASL) : Comprehensive Multidisciplinary Approach for Obesity and/or NAFLD Korean

Date / Time	Nov. 19 (Fri), 15:55-17:25
Channel	Channel 3
Chair(s)	Sung Kyu Choi (Chonnam National Univ., Korea) So Young Kwon (Konkuk Univ., Korea)
Speakers	15:55-16:17	Clinical significance of obese and non-obese Fatty Liver Disease Jeongju Yoo (Soonchunhyang Univ., Korea)
	16:17-16:39	Radiological assessment of NAFLD Dong Ho Lee (Seoul National Univ., Radiology, Korea)
	16:39-17:01	Endoscopic therapies for obesity in NAFLD Seung-Joo Nam (Kangwon National Univ., Korea)
	17:01-17:23	Bariatric surgery in the management of obesity in NAFLD Jong-Han Kim (Korea Univ., Surgery, Korea)

PG Course 05 (KASL) : Updated KASL Practice Guideline of NAFLD Korean

Date / Time	Nov. 20 (Sat), 08:30-10:00
Channel	Channel 5
Chair(s)	Yong Kyun Cho (Sungkyunkwan Univ., Korea) Jin-Woo Lee (Inha Univ. Hosp., Korea)
Speakers	08:30-08:52	Definition, epidemiology, and co-morbidities: Focusing on the changes Sang Gyune Kim (Soonchunhyang Univ., Korea)
	08:52-09:14	Diagnostic algorithm for identifying high-risk patients in NAFLD Sang Bong Ahn (Eulji Univ., Korea)
	09:14-09:36	Updates on non-invasive assessment of liver steatosis and fibrosis Hye Won Lee (Yonsei Univ., Korea)
	09:36-09:58	Current and future pharmacological and surgical treatment options Yuri Cho (National Cancer Center, Korea)